Sangamo Therapeutics (SGMOQ) Price to Book (2010 - 2025)

Sangamo Therapeutics has reported Price to Book for 16 years, with the latest figure at 8.25 in Q4 2025.

• On a quarterly basis, Price to Book fell 186.51% year-over-year to 8.25 in Q4 2025; TTM through Dec 2025 was 8.25, a 186.51% decrease from a year earlier, with the FY2025 full-year figure at 8.25, down 186.51% from the prior year.
• Price to Book was 8.25 for Q4 2025 at Sangamo Therapeutics, down from 36.11 in the prior quarter.
• The five-year high for Price to Book was 36.11 in Q3 2025, with the low at 8.25 in Q4 2025.
• Average Price to Book over 5 years is 5.52, with a median of 2.57 recorded in 2022.
• The largest YoY upside for Price to Book was 10544.55% in 2025 against a maximum downside of 186.51% in 2025.
• Over 5 years, Price to Book stood at 2.92 in 2021, then slumped by 39.1% to 1.78 in 2022, then tumbled by 34.64% to 1.16 in 2023, then soared by 721.55% to 9.53 in 2024, then tumbled by 186.51% to 8.25 in 2025.
• The last three Price to Book figures came in at 8.25 (Q4 2025), 36.11 (Q3 2025), and 8.31 (Q2 2025), per Business Quant data.